Clinical Trials
7 trialsNCT05949775 2023-07-18
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Stemirna Therapeutics
Phase NA Unknown
NCT05338957 2022-12-01
A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.
Shanghai Miracogen Inc.
Phase 1/2 Unknown
NCT03792958 2022-11-14
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
AnewPharma
Phase 1 Unknown
NCT05478785 2022-07-29
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2 Unknown
NCT05277454 2022-03-14
Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT
Hutchmed
Phase 1 Unknown
NCT04226066 2020-12-07
Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors
Tasly Tianjin Biopharmaceutical Co., Ltd.
Phase 1/2 Unknown
NCT03047811 2017-02-09
The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors
Fudan University
Phase NA Unknown